Refametinib (Standard)
Refametinib (Standard) is the analytical standard of Refametinib. This product is intended for research and analytical applications. Refametinib (BAY 869766; RDEA119) is an orally available, potent, non-ATP-competitive, selective, allosteric MEK1/MEK2 inhibitor with IC50s of 19 nM and 47 nM, respectively.
Product Specifications
CAS Number
[923032-37-5]
UNSPSC
12352100
Target
MEK; Reference Standards
Related Pathways
MAPK/ERK Pathway; Others
Field of Research
Cancer
Smiles
O=S(C1(C[C@H](O)CO)CC1)(NC(C(NC(C(F)=C2)=CC=C2I)=C3F)=C(OC)C=C3F)=O
Molecular Formula
C19H20F3IN2O5S
Molecular Weight
572.34
References & Citations
[1]Iverson C, et al. RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer. Cancer Res. 2009 Sep 1;69 (17) :6839-47.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
124164-ML490 100 µL
IDNK (Probable Gluconokinase, Gluconate Kinase, C9orf103, bA522I20.2) (MaxLight 490)
Ask
View Details 
039481-FITC 200 µL
OR7G1, NT (OR7G1, OR7G1P, Olfactory receptor 7G1, Olfactory receptor 19-15, Olfactory receptor OR19-8) (FITC) discontinued
Ask
View Details 